Literature DB >> 7606737

Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis.

M Toyooka1, M Konishi, R Kikuchi-Yanoshita, T Iwama, M Miyaki.   

Abstract

We analyzed somatic mutations of the adenomatous polyposis coli (APC), p53, and K-ras genes in gastroduodenal polyps and normal gastroduodenal mucosa from 21 familial adenomatous polyposis patients, using PCR-single-strand conformation polymorphism and direct sequencing methods. Seventy-five polyps were obtained from these patients endoscopically or surgically, and they were histopathologically diagnosed as mild adenoma, moderate adenoma, severe adenoma, adenocarcinoma, and fundic gland polyp. Examining the APC-coding region where somatic mutations in colorectal tumors are known to be clustered, we detected 47 somatic mutations. The frequency of mutation detected was 6 of 9 (67%) in ampullary adenomas, 1 of 2 (50%) in ampullary adenocarcinoma, 11 of 24 (46%) in non-ampullary adenomas, 26 of 29 (90%) in gastric adenomas, and 3 of 11 (27%) in gastric fundic gland polyps. These mutations frequently occurred at codons 1450, 1462-1465, and 1554-1556, the third being a newly found hot spot. All mutations formed stop codons that resulted in truncated APC proteins. K-ras mutation was detected only in an ampullary adenocarcinoma, and p53 mutation was not detected in any of the tumors analyzed. There was no somatic mutation detected in samples of flat mucosa that were diagnosed as normal mucosa both endoscopically and histopathologically. Frequent APC mutations in mild and small adenomas, similar to the findings in severe and large adenomas, suggested that the genetic change in the APC gene occurs in an early stage of forming gastroduodenal adenomas. Moreover, the presence of somatic APC mutations in fundic gland polyps suggests that inactivation of the APC gene plays a role not only in forming adenomas but also in forming hyperplastic polyps in fundic gland mucosa, and there may be some additional steps to the adenoma-carcinoma sequence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606737

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  FAP: another indication to treat H pylori.

Authors:  B Leggett
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.

Authors:  Susan C Abraham; Seun Ja Park; Lilian Mugartegui; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis.

Authors:  M Miyaki; T Iijima; R Ishii; T Hishima; T Mori; K Yoshinaga; H Takami; T Kuroki; T Iwama
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".

Authors:  A J Rowan; H Lamlum; M Ilyas; J Wheeler; J Straub; A Papadopoulou; D Bicknell; W F Bodmer; I P Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 5.  Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

Authors:  María Sereno; Cristina Aguayo; Carmen Guillén Ponce; César Gómez-Raposo; Francisco Zambrana; Miriam Gómez-López; Enrique Casado
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

Review 6.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.

Authors:  Michelle C Gallagher; Robin K S Phillips; Steffen Bulow
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 7.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

8.  An insight into the genetic pathway of adenocarcinoma of the small intestine.

Authors:  J M D Wheeler; B F Warren; N J McC Mortensen; H C Kim; S C Biddolph; G Elia; N E Beck; G T Williams; N A Shepherd; A C Bateman; W F Bodmer
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

9.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis.

Authors:  F Maire; P Hammel; B Terris; S Olschwang; D O'Toole; A Sauvanet; L Palazzo; P Ponsot; B Laplane; P Lévy; P Ruszniewski
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.